Zachariah Jonasson

Founded in 1993, Seaflower Ventures is a life science focused venture capital firm located in Waltham Massachusetts.

Veritas Medicine, Inc. operates an online database of clinical trials. It offers patient enrollment solutions to determine eligibility for upcoming clinical trials. The company was founded by Robert Adelman, Joshua Schultz, and Stephen Knight in 1999 and is headquartered in Cambridge, MA.

MetaWorks, Inc. provides consulting services for the development and commercialization of biopharmaceutical products, devices, and healthcare. The company is based in Medford, MA. MetaWorks was acquired by United BioSource Corp. on January 17, 2006.

Phoenix Venture Partners LLC (Phoenix Venture Partners) is a venture capital firm founded in 2010 by John Chen, Zach Jonasson, Frank Levinson and David Soane. The firm is headquartered in San Mateo, California.

Crop Enhancement LLC develops green formulation technologies for improving agricultural production. It offers three environmental products platform: CropCoat Produce Protection, Agrochemical Encapsulatio, and Particle Stabilization. The company was founded by David Soane and Zach Jonasson in 2011 and is headquartered in Cambridge, MA.

Broadspot Imaging Corp. engages in the development of diagnostic medical devices for eye care. It leverages imaging technologies and small-scale, cloud-connected electronics to replace diagnostic instruments with handheld instruments and a series of services. The company was founded by Tushar Ranchod and is headquartered in Albuquerque, NM.

Green Theme Technologies, Inc. engages in the technologies that eliminates water usage and pollution services. It develops and patents the GTT thermal soon became ChemStik technology that provides dry textile finishing technology. The company was founded by Gary S. Selwyn in 2011 and is headquartered in Albuquerque, NM.

Sentinel Monitoring Systems, Inc. develops real-time and near-real-time systems to monitor the effectiveness of microbial control. The Sentinel Online Monitor is a multivariate spectroscopic analyzer for real-time monitoring of bioburden and other target analytes. The Sentinel Sample Collector automatically collects excursion samples identified by online monitors and/or periodic samples during production runs. The company was founded by Bill Puen in 2014 and is headquartered in Tucson, AZ.

Xandar Kardian, Inc. engages in the development of proprietary software solutions utilizing IR-UWB RADAR technology. Its application is for smart building, security, and vehicle use. The company was founded by Sung Ho Cho in 2017 and is headquartered in Toronto, Canada.

Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.

Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ.